Impact of Immunotherapy on the Treatment of Prostate Cancer
August 6th 2015Matthew Cooperberg, MD, genitourinary cancer specialist, University of California San Francisco, discusses the impact of immunotherapy on the treatment of prostate cancer. Cooperberg believes immunotherapy treatment should be used earlier in the course of the disease.
Watch
Monoclonal Antibodies for the Treatment of Patients With Multiple Myeloma
July 31st 2015Ravi Vij, MD, associate professor of medicine, Division of Oncology, Section of Bone Marrow Transplant, Washington University School of Medicine, discusses the monoclonal antibody daratumumab for the treatment of patients with heavily pretreated multiple myeloma.
Watch
Phase II ADAPT Trial in Patients With HER2+ and HR+ Early Breast Cancer
July 31st 2015Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota, discusses the results of the phase II ADAPT trial.
Watch
Neoadjuvant Chemotherapy for the Treatment of Patients With Bladder Cancer
July 27th 2015Alexander Kutikov, MD, FACS, attending surgeon, Urologic Oncology, associate professor, Urologic Oncology, Fox Chase Cancer Center, discusses neoadjuvant chemotherapy for the treatment of patients with bladder cancer.
Watch
Advantages of Using Y-90 for the First-Line Treatment of Patients With Liver Metastases from mCRC
July 24th 2015Dirk Arnold, MD, director of the Department of Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany, discusses the advantages of using yttrium-90 (Y-90) as the first line treatment for patients with liver metastases from metastatic colorectal cancer (mCRC).
Watch
Study of Vemurafenib Combined With a MEK Inhibitor
July 23rd 2015Anna C. Pavlick, DO, co-director, Melanoma Program, assistant director, Clinical Research Education, associate professor, Departments of Medicine and Dermatology, Langone Medical Center, New York University, discusses the study of vemurafenib combined with a MEK inhibitor.
Watch
Patient Selection for Premenopausal Endocrine Therapy
July 23rd 2015Hope S. Rugo, MD, clinical professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology Clinical Trials Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, discusses patient selection for premenopausal endocrine therapy.
Watch
Challenges Medical Oncologists Will Face Due To Health Care Reform
July 22nd 2015Debra Patt, MD, MPH, MBA, medical oncologist, director of Public Policy, Texas Oncology, director of Health Care Informatics, McKesson Specialty Health and The US Oncology Network, discusses the challenges that medical oncologists will face due to health care reform.
Watch
Treatment of Patients With HPV Associated Locally Advanced Oropharynx Cancer
July 20th 2015Barbara A. Burtness, MD, professor of medicine, clinical research program leader, Head and Neck Cancers Program, co-director, Developmental Therapeutics Research Program, Yale Cancer Center, discusses the treatment of patients with HPV associated locally advanced oropharynx cancer.
Watch
Adverse Effects of Anastrozole in Patients With DCIS
July 17th 2015Adam M. Brufsky, MD, PhD, ​professor of medicine, University of Pittsburgh School of Medicine, associate director of clinical investigation, University of Pittsburgh Cancer Institute, discusses the adverse effects, as well as future treatments, of anastrozole in patients with ductal carcinoma In situ (DCIS).
Watch
Adverse Events of Nivolumab in Patients With Advanced, Non-Squamous NSCLC
July 17th 2015Mark A. Socinski, MD, professor, Medicine and Cardiothoracic Surgery, director, Lung Cancer Section, Division of Hematology/Oncology, clinical associate director, Lung SPORE, co-director, UPMC Lung Cancer Center of Excellence, co-leader, UPCI Lung Cancer Program, University of Pittsburgh, discusses the adverse events, as well as the overall significance, of nivolumab in patients with advanced non-squamous non-small cell lung cancer (NSCLC).
Watch
A Study on Two Adjuvant Trials in Patients With Stage III Colon Cancer
July 16th 2015Frank A. Sinicrope, MD, medical oncologist, Departments of Gastroenterology and Hepatology and Oncology, Cancer Center, Mayo Clinic discusses a study on two adjuvant trials in patients with stage III colon cancer.
Watch